Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Koriand'r Williams, M.D.
EIR
•Koriand'r Williams, M.D.•December 22, 2021

Koriand'r Williams, M.D. – FDA EIR, Dec 22, 2021

Record Details

An FDA inspection of Koriand’R Williams, M.D., operating as Elixir Research Group in Houston, TX, was conducted from December 13 to December 22, 2021. This was a high-priority "For Cause" assignment under the Bioresearch Monitoring Compliance Program, investigating two clinical studies involving investigational products. The regulatory framework for the inspection included 21 CFR Parts 50, 56, 58, 11, and 312.

The inspection revealed two primary objectionable conditions, resulting in the issuance of an FDA Form 483. First, the clinical investigator failed to adequately supervise the investigations, signing off on incomplete staff paperwork that conflicted with supporting documentation such as laboratory results and EKGs. This led to inconsistencies in subject eligibility records. Second, there was a failure to prepare and maintain accurate case histories, with inadequate documentation of critical observations and data. This included instances of under-reporting of adverse events and study deviations, and a lack of proper clinical investigator progress notes for abnormal findings, even those deemed not reportable by protocol (e.g., subjects with abnormal ECGs or elevated liver enzymes lacking appropriate follow-up documentation).

The firm chose to respond to the FDA 483 in writing, indicating an obligation to address these findings and implement corrective actions to ensure compliance with regulatory requirements for clinical investigations.

Company
Koriand'r Williams, M.D.
Inspection date
December 22, 2021
Product type
drugs
Office
Dallas District Office
People
  • Anya D. Lockett-Evans
  • Habacuc V. Barrera
View Company Profile

ID · 1f78c1eb-23ec-4b0d-923b-149725d3b965

Violation Codes7
21 CFR 312.6021 CFR 5821 CFR 5021 CFR 1121 CFR 312.62(b)21 CFR 5621 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Koriand'r Williams, M.D.
  • 483 - 2021-12-22December 22, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Koriand'r Williams, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.